Back to Startup Insights
Averna Therapeutics
Averna Therapeutics is a biotechnology company focused on developing innovative therapeutics with translational expertise.
Headquarters
Boston, USA
Year Founded
2022
Founders
Dr. Lisa Brown
Country
United States
Financial Information
Funding Stage
Series C
Recent Funding
$82 M
Funding By
Flagship Pioneering
Core Technology
Translational therapeutics
Product Type
Drug
Pipeline Stage (Very Important)
Phase II
Regulatory Status
- IND Filed: Yes
- FDA/EMA Status: FDA IND
- Clinical Trial Registration: NCT87654321
- Patents / IP Status: Granted
Partnerships
Pharma Collaborations
Novartis
Academic / Hospital Tie-ups
Harvard Medical School
CRO/CDMO Partnerships
None
Market & Differentiation
Translational expertise